Clinical Experience on the Treatment of Pre/Perimenopausal Patients with HR+,HER2- MBC

Introduction

Take This Event

Dr. Alistair Ring joins us live from the UK to discuss his clinical experience in the treatment of pre/perimenopausal patients with HR+, HER2- metastatic breast cancer. The session will be moderated by Dr. Abdullah Altwaigri who will also share some of his experience from a local perspective. Discussion followed by live Q&A.

Objectives

- Understand the clinical experience of treating pre/perimenopausal patients with HR+, HER2- MBC
- Understand best practices on managing side effects of Abemaciclib side effects in pre/perimenopausal patients

See Registration Policies, Cancellations & Refunds